Laboratory characteristics of pregnant compared to non-pregnant women infected with SARS-CoV-2

被引:26
|
作者
Mohr-Sasson, Aya [1 ,2 ]
Chayo, Jennifer [1 ,2 ]
Bart, Yossi [1 ,2 ]
Meyer, Raanan [1 ,2 ]
Sivan, Eyal [1 ,2 ]
Mazaki-Tovi, Shali [1 ,2 ]
Yinon, Yoav [1 ,2 ]
机构
[1] Sheba Med Ctr, Dept Obstet & Gynecol, IL-52621 Ramat Gan, Israel
[2] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel
关键词
Pregnant women; Infection; COVID-19; SARS-CoV-2; Laboratory characteristics;
D O I
10.1007/s00404-020-05655-7
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Key message Laboratory characteristics of SARS-CoV-2 infection did not differ between pregnant and non-pregnant women. A trend of lower lymphocyte count was observed in the pregnant women group Purpose Laboratory abnormalities, which characterize SARS-CoV-2 infection have been identified, nevertheless, data concerning laboratory characteristics of pregnant women with SARS-CoV-2 are limited. The aim of this study is to evaluate the laboratory characteristics of pregnant compared to non-pregnant women with SARS-CoV-2 infection. Methods A retrospective cohort study of all pregnant women with SARS-CoV-2 who were examined at the obstetric emergency room in a tertiary medical center between March and April 2020. Patients were compared with non-pregnant women with SARS-CoV-2 matched by age, who were examined at the general emergency room during the study period. All patients were confirmed for SARS-CoV-2 on admission. Clinical characteristics and laboratory results were compared between the groups. Results Study group included 11 pregnant women with SARS-CoV-2, who were compared to 25 non-pregnant controls. Respiratory complaints were the most frequent reason for emergency room visit, and were reported in 54.5% and 80.0% of the pregnant and control groups, respectively (p = 0.12). White blood cells, hemoglobin, platelets, and liver enzymes counts were within the normal range in both groups. Lyphocytopenia was observed in 45.5% and 32% of the pregnant and control groups, respectively (p = 0.44). The relative lymphocyte count to WBC was significantly reduced in the pregnant group compared to the controls [13.6% (4.5-19.3) vs. 26.5% (15.7-29.9);p = 0.003]. C-reactive protein [20(5-41) vs. 14 (2-52) mg/dL;p = 0.81] levels were elevated in both groups but without significant difference between them. Conclusion Laboratory characteristics of SARS-CoV-2 infection did not differ between pregnant and non-pregnant women, although a trend of lower lymphocyte count was observed in the pregnant women group.
引用
收藏
页码:629 / 634
页数:6
相关论文
共 50 条
  • [21] Outcomes in Adolescent Pregnant Patients Infected With SARS-CoV-2
    Murrin, Ellen M.
    Nguyen, Anh Q.
    Hitchings, Laura
    Nasrallah, Sebastian
    Wang, Jenny
    Gomez, Luis M.
    OBSTETRICS AND GYNECOLOGY, 2022, 139 : 72S - 72S
  • [22] Critical Care in SARS-CoV-2 Infected Pregnant Women: A Prospective Multicenter Study
    Alvarez Bartolome, Ana
    Abdallah Kassab, Nadia Akram
    Cruz Melguizo, Sara
    de la Cruz Conty, Maria Luisa
    Forcen Acebal, Laura
    Abascal Saiz, Alejandra
    Pintado Recarte, Pilar
    Martinez Varea, Alicia
    Cerrillos Gonzalez, Lucas
    Garcia Fernandez, Javier
    Martinez Perez, Oscar
    BIOMEDICINES, 2022, 10 (02)
  • [23] Maternal-fetal immune responses in pregnant women infected with SARS-CoV-2
    Garcia-Flores, Valeria
    Romero, Roberto
    Xu, Yi
    Theis, Kevin
    Arenas-Hernandez, Marcia
    Miller, Derek
    Peyvandipour, Azam
    Galaz, Jose
    Levenson, Dustyn
    Bhatti, Gaurav
    Gershater, Meyer
    Pusod, Errile
    Kracht, David
    Florova, Violetta
    Leng, Yaozhu
    Tao, Li
    Faucett, Megan
    Para, Robert
    Hsu, Chaur-Dong
    Zhang, Gary
    Tarca, Adi
    Pique-Regi, Roger
    Gomez-Lopez, Nardhy
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [24] Maternal-fetal immune responses in pregnant women infected with SARS-CoV-2
    Valeria Garcia-Flores
    Roberto Romero
    Yi Xu
    Kevin R. Theis
    Marcia Arenas-Hernandez
    Derek Miller
    Azam Peyvandipour
    Gaurav Bhatti
    Jose Galaz
    Meyer Gershater
    Dustyn Levenson
    Errile Pusod
    Li Tao
    David Kracht
    Violetta Florova
    Yaozhu Leng
    Kenichiro Motomura
    Robert Para
    Megan Faucett
    Chaur-Dong Hsu
    Gary Zhang
    Adi L. Tarca
    Roger Pique-Regi
    Nardhy Gomez-Lopez
    Nature Communications, 13
  • [25] Evaluation of T-cell subsets in pregnant women infected with SARS-CoV-2
    Kulhan, M.
    Ozdemir, H.
    Bilgi, A.
    Celik, C.
    Demir, N. Aktug
    Dagi, H. Turk
    Ucar, M. G.
    Kulhan, N. G.
    Artac, H.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 124
  • [26] Variation in the Urinary Microbiome of Pregnant Women Compared to Non-Pregnant Controls
    Thomas-White, Krystal J.
    Waters, Thaddeus P.
    Jacobs, Kristin M.
    Grayczyk, James
    Hilt, Evann E.
    Goodman, Jean R.
    Wolfe, Alan J.
    REPRODUCTIVE SCIENCES, 2016, 23 : 120A - 120A
  • [27] Immunological markers in HIV-infected pregnant and non-pregnant women
    Vimercati, A
    Greco, P
    Lopalco, PL
    Loverro, G
    Fiore, JR
    Bettocchi, S
    Angarano, G
    Selvaggi, L
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2000, 90 (01): : 37 - 41
  • [28] Clinical Manifestation and Laboratory Characteristics of SARS-CoV-2Infection in Pregnant Women
    Chunchen Wu
    Wenzhong Yang
    Xiaoxue Wu
    Tianzhu Zhang
    Yaoyao Zhao
    Wei Ren
    Jianbo Xia
    Virologica Sinica, 2020, (03) : 305 - 310
  • [29] Clinical Manifestation and Laboratory Characteristics of SARS-CoV-2Infection in Pregnant Women
    Chunchen Wu
    Wenzhong Yang
    Xiaoxue Wu
    Tianzhu Zhang
    Yaoyao Zhao
    Wei Ren
    Jianbo Xia
    Virologica Sinica, 2020, 35 (03) : 305 - 310
  • [30] Natural history of SARS-CoV-2 infection in pregnant women
    Roques, Pierre
    Egloff, Charles
    Picone, Nicolas
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2023, 158